Investigators from National Center for Cardiovascular Diseases Report New Data on Tissue Engineering (Extracellular Matrix/glycopeptide Hybrid Hydrogel As an Immunomodulatory Niche for Endogenous Cardiac Repair After Myocardial Infarction).

Keywords: Beijing; People's Republic of China; Asia; Alcohols; Bioengineering; Biomedical Engineering; Biomedicine; Biotechnology; Cardiology; Cellular Structures; Connective Tissue Cells; Extracellular Matrix; Extracellular Space; Glycopeptides; Health and Medicine; Heart Attack; Heart Disease; Heart Disorders and Diseases; Hydrogel; Immunology; Inflammation; Macrophages; Mononuclear Phagocyte System; Myeloid Cells; Myocardial Infarction; Myocardial Ischemia; Organic Chemicals; Peptides and Proteins; Phagocytes; Polyethylene Glycols; Tissue Engineering; Tissue Regeneration; Vascular Diseases and Conditions EN Beijing People's Republic of China Asia Alcohols Bioengineering Biomedical Engineering Biomedicine Biotechnology Cardiology Cellular Structures Connective Tissue Cells Extracellular Matrix Extracellular Space Glycopeptides Health and Medicine Heart Attack Heart Disease Heart Disorders and Diseases Hydrogel Immunology Inflammation Macrophages Mononuclear Phagocyte System Myeloid Cells Myocardial Infarction Myocardial Ischemia Organic Chemicals Peptides and Proteins Phagocytes Polyethylene Glycols Tissue Engineering Tissue Regeneration Vascular Diseases and Conditions 188 188 1 07/17/23 20230717 NES 230717 2023 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on Biomedical Engineering - Tissue Engineering have been published. Our news editors obtained a quote from the research from National Center for Cardiovascular Diseases, "Herein, a hybrid hydrogel coassembled by acellular cardiac extracellular matrix (ECM) and immunomodulatory glycopeptide is developed for endogenous tissue regeneration after MI. [Extracted from the article]